Summary

KEY FINDINGS
The China 3D bioprinting market is anticipated to register a CAGR of 16.91% during the forecast period, 2023-2030. As per stats, there are around 1.5 million patients who need organ transplantations in China annually. However, only less than 1% are able to obtain suitable organs. The rising organ transplantation demands are expected to offer lucrative growth opportunities for 3D bioprinting technology.
MARKET INSIGHTS
The China 3D bioprinting market growth is propelled by factors like increasing investments, growing innovations, and rising R&D centers. The country has witnessed substantial progress in regenerative medicine during the last decade. This is attributed to the surging aging population, lifestyle changes, economic progress, and the high prevalence of chronic conditions. Besides, these factors have projected the unmet needs for the treatment of chronic degenerative diseases and acute traumas.
Furthermore, China is among the prominent countries globally for regenerative medicine research, as indicated by scientific publications, issued patents, and increased gross expenditure. Moreover, the country has emerged as an early adopter of advanced technologies like 3D bioprinting technologies. Additionally, most vendors are focused on launching advanced bioprinters.
COMPETITIVE INSIGHTS
The key players in the China 3D bioprinting market include Cyfuse Biomedical KK, CollPlant Biotechnologies Ltd, EnvisionTEC Ṁ Inc, CELLINK, Inventia Life Science Pty Ltd, REGENHU, etc.
Our report offerings include:
• Explore key findings of the overall market
• Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
• Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
• Market Segmentation caters to a thorough assessment of key segments with their market estimations
• Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
• Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
• Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
• Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

ページTOPに戻る

Table of Contents

TABLE OF CONTENTS
1. RESEARCH SCOPE & METHODOLOGY
1.1. STUDY OBJECTIVES
1.2. METHODOLOGY
1.3. ASSUMPTIONS & LIMITATIONS
2. EXECUTIVE SUMMARY
2.1. MARKET SIZE & ESTIMATES
2.2. COUNTRY SNAPSHOT
2.3. COUNTRY ANALYSIS
2.4. SCOPE OF STUDY
2.5. CRISIS SCENARIO ANALYSIS
2.5.1. IMPACT OF COVID-19 ON 3D BIOPRINTING MARKET
2.6. MAJOR MARKET FINDINGS
2.6.1. EMERGENCE OF 4D BIOPRINTING AS A SUBSTITUTE FOR 3D BIOPRINTING
2.6.2. PERSONALIZED MEDICINE LIKELY TO BOOST 3D BIOPRINTING
2.6.3. RISING INTEREST IN THE APPLICATION OF BIOPRINTING AGAINST THE SARS-COV-2 VIRUS
3. MARKET DYNAMICS
3.1. KEY DRIVERS
3.1.1. SURGING GERIATRIC POPULATION
3.1.2. TECHNOLOGICAL ADVANCEMENTS AND R&D INVESTMENTS
3.1.3. RISING FOCUS ON REGENERATIVE MEDICINE
3.1.4. HIGH PREVALENCE OF CHRONIC CONDITIONS
3.2. KEY RESTRAINTS
3.2.1. OPERATIONAL CHALLENGES DURING MANUFACTURING
3.2.2. EXORBITANT COSTS OF 3D BIOPRINTERS
3.2.3. LACK OF TRAINED PROFESSIONALS
4. KEY ANALYTICS
4.1. PARENT MARKET ANALYSIS
4.2. KEY MARKET TRENDS
4.3. PORTER’S FIVE FORCES ANALYSIS
4.3.1. BUYERS POWER
4.3.2. SUPPLIERS POWER
4.3.3. SUBSTITUTION
4.3.4. NEW ENTRANTS
4.3.5. INDUSTRY RIVALRY
4.4. GROWTH PROSPECT MAPPING
4.4.1. GROWTH PROSPECT MAPPING IN CHINA
4.5. MARKET MATURITY ANALYSIS
4.6. MARKET CONCENTRATION ANALYSIS
4.7. VALUE CHAIN ANALYSIS
4.7.1. DESIGN & SOFTWARE PROVIDERS
4.7.2. PROTOTYPE PRODUCTION
4.7.3. DISTRIBUTION
4.7.4. END-USERS
5. MARKET BY COMPONENT
5.1. 3D BIOPRINTER
5.2. BIOINK
6. MARKET BY BIOMATERIAL
6.1. HYDROGEL
6.2. LIVING CELLS
6.3. EXTRACELLULAR MATRICES
6.4. OTHER BIOMATERIALS
7. MARKET BY TECHNOLOGY
7.1. MAGNETIC LEVITATION BIOPRINTING
7.2. INKJET-BASED BIOPRINTING
7.3. SYRINGE/EXTRUSION-BASED BIOPRINTING
7.4. LASER-ASSISTED BIOPRINTING
7.5. OTHER TECHNOLOGIES
8. MARKET BY APPLICATION
8.1. DRUG TESTING & DEVELOPMENT
8.2. TISSUE ENGINEERING & REGENERATIVE MEDICINE
8.3. FOOD TESTING
8.4. RESEARCH
8.5. OTHER APPLICATIONS
9. MARKET BY END-USER
9.1. HOSPITALS
9.2. BIOPHARMACEUTICALS COMPANIES
9.3. RESEARCH ORGANIZATIONS AND ACADEMIC INSTITUTES
9.4. OTHER END-USERS
10. COMPETITIVE LANDSCAPE
10.1. KEY STRATEGIC DEVELOPMENTS
10.1.1. MERGERS & ACQUISITIONS
10.1.2. PRODUCT LAUNCHES & DEVELOPMENTS
10.1.3. PARTNERSHIPS & AGREEMENTS
10.2. COMPANY PROFILES
10.2.1. CELLINK
10.2.1.1. COMPANY OVERVIEW
10.2.1.2. PRODUCTS LIST
10.2.1.3. STRENGTHS & CHALLENGES
10.2.2. COLLPLANT BIOTECHNOLOGIES LTD
10.2.2.1. COMPANY OVERVIEW
10.2.2.2. PRODUCTS LIST
10.2.3. CYFUSE BIOMEDICAL KK
10.2.3.1. COMPANY OVERVIEW
10.2.3.2. PRODUCTS LIST
10.2.3.3. STRENGTHS & CHALLENGES
10.2.4. ENVISIONTEC INC
10.2.4.1. COMPANY OVERVIEW
10.2.4.2. PRODUCTS LIST
10.2.4.3. STRENGTHS & CHALLENGES
10.2.5. INVENTIA LIFE SCIENCE PTY LTD
10.2.5.1. COMPANY OVERVIEW
10.2.5.2. PRODUCTS LIST
10.2.6. REGENHU
10.2.6.1. COMPANY OVERVIEW
10.2.6.2. PRODUCTS LIST
10.2.6.3. STRENGTHS & CHALLENGES